Candriam Equities L Biotech.V USD Acc/ LU0317020203 /
| NAV9/21/2023 | Chg.-18.0599 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 1,802.2700USD | -0.99% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 3.61 | 5.39 | -8.19 | 12.61 | -2.42 | 3.86 | -12.36 | 8.75 | -2.82 | - |
| 2017 | 5.51 | 6.90 | -0.08 | 1.23 | -3.06 | 9.25 | 2.56 | 6.40 | 0.81 | -6.34 | 0.29 | 1.54 | +26.78% |
| 2018 | 6.88 | -4.67 | -1.88 | -3.09 | 4.69 | 0.99 | 4.63 | 4.22 | -2.00 | -13.93 | 4.22 | -8.45 | -10.11% |
| 2019 | 13.27 | 3.46 | -0.54 | -4.84 | -4.71 | 9.42 | -2.29 | -2.34 | -4.19 | 10.53 | 11.85 | 2.47 | +33.93% |
| 2020 | -5.17 | -1.12 | -4.99 | 12.89 | 9.37 | 1.42 | -2.84 | 0.94 | 0.78 | -2.79 | 9.82 | 3.08 | +21.34% |
| 2021 | 1.90 | -2.51 | -4.18 | 2.81 | -2.18 | 6.45 | -1.37 | 4.00 | -4.15 | 0.25 | -4.29 | 2.37 | -1.59% |
| 2022 | -10.77 | -1.96 | 5.73 | -7.54 | -3.35 | 3.08 | 4.65 | 1.14 | -1.90 | 7.00 | 6.18 | -2.79 | -2.30% |
| 2023 | 3.02 | -5.67 | 0.45 | 2.29 | -1.19 | 1.26 | -0.13 | -0.15 | -3.39 | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 14.41% | 13.19% | 17.55% | 21.00% | 23.58% |
| Sharpe ratio | -0.64 | -0.14 | 0.15 | -0.13 | 0.03 |
| Best month | +3.02% | +2.29% | +7.00% | +9.82% | +13.27% |
| Worst month | -5.67% | -3.39% | -5.67% | -10.77% | -13.93% |
| Maximum loss | -10.19% | -7.25% | -11.48% | -30.61% | -30.61% |
| Outperformance | -1.00% | - | -1.80% | +3.49% | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,802.2700 | +6.55% | +3.49% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 196.4300 | -2.35% | - | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,830.4399 | +3.17% | -3.47% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,973.0100 | -1.35% | +13.63% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,079.5701 | -1.86% | +6.29% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 322.4400 | -1.94% | +9.07% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 288.0200 | -1.47% | +15.37% | |
| Candriam Equities L Biotech.R CH... | reinvestment | 181.0200 | +1.47% | -3.93% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,607.4301 | +6.59% | +5.52% | |
| Candriam Equities L Biotech.I US... | reinvestment | 4,983.7998 | +4.99% | +4.19% | |
| Candriam Equities L Biotech.V US... | reinvestment | 527.8700 | +5.02% | +0.90% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 175.6800 | +2.96% | -4.17% | |
| Candriam Equities L Biotech.R US... | reinvestment | 235.7200 | +4.98% | +5.78% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 182.1800 | +3.28% | -1.85% | |
| Candriam Equities L Biotech.C US... | reinvestment | 739.1700 | +5.42% | +2.25% | |
| Candriam Equities L Biotech.C US... | paying dividend | 679.1400 | +5.39% | +2.15% |
Performance
| YTD | -3.76% | ||
|---|---|---|---|
| 6 Months | +1.05% | ||
| 1 Year | +6.55% | ||
| 3 Years | +3.49% | ||
| 5 Years | +25.13% | ||
| 10 Years | - | ||
| Since start | +80.23% | ||
| Year | |||
| 2022 | -2.30% | ||
| 2021 | -1.59% | ||
| 2020 | +21.34% | ||
| 2019 | +33.93% | ||
| 2018 | -10.11% | ||
| 2017 | +26.78% | ||